Stock Price
44.42
Daily Change
-1.06 -2.33%
Monthly
-6.17%
Yearly
-16.74%
Q1 Forecast
44.07

Recordati reported EUR384.01M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Almirall EUR 517.4M 32K Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Orion EUR 367.1M 64.9M Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025